2026 Arkansas Neurological Society Annual Meeting and Comprehensive Update

Saturday, September 26, 2026, 7:30 AM - 4:00 PM CT, Little Rock, AR

This educational conference is designed to provide a comprehensive review of the latest scientific advances in the diagnosis and management of neurological disorders. Featuring leading experts in the field, the program will cover emerging diagnostic technologies, evidence-based treatment strategies, and recent research findings across a wide range of neurology subspecialties. Topics will include epilepsy, movement disorders, multiple sclerosis, stroke, neuroimmunology, neuromuscular disorders, and more. Attendees will gain valuable insights to enhance clinical practice and improve patient care in the dynamic field of clinical neurology.

AMA Credit Designation Statement

The University of Arkansas for Medical Sciences designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation Statement

The University of Arkansas for Medical Sciences designates this live activity for a maximum of 4.75 ANCC contact hours.  Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.

ACPE Credit Designation Statement

These knowledge-based activities will provide pharmacists up to 4.75 contact hours or 0.475 CEU.  CE credit information, based on verification of live attendance and completion of the program evaluation, will be provided to NABP within 60 days after the activity completion. 

AAPA Credit Designation Statement

The University of Arkansas for Medical Sciences has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Providers

Many allied health care licensing boards will accept attendance at a CME activity approved for AMA PRA Category 1 Credits^TM if the topics are within the health care professional’s scope of practice.  There is no guarantee that attendance at this activity will be accepted by your licensing board to fulfil your CE requirements.  You are responsible for sending the documentation of attendance to your licensing board.

1. Discuss the fundamental principles and mechanisms underlying neurological conditions.
2. Review clinical updates on both traditional and new treatments for neurological conditions.
3. Explore optimal management strategies for neurological conditions using medications and other therapies.

Registration

*Pre-registration ends September 18, 2025 at 11:59 pm. 

Registration is free for this activity.  However, we would still like each attendee to register for accreditation purposes.

AMA PRA Category 1 Credits™ (4.75 hours), AAPA - American Academy of PAs Category 1 CME (4.75 hours), ACPE - Accreditation Council for Pharmacy Education (4.75 hours), ANCC - American Nurses Credentialing Center (4.75 hours), Non-Physician AMA PRA Category 1 Credits™ (4.75 hours)

In support of improving patient care, University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

University of Arkansas for Medical Sciences Office of Continuing Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.